Lecap Asset Management Ltd. Takes Position in Confluent, Inc. $CFLT

Key Points

• Lecap Asset Management Ltd. acquired 22,785 shares of Confluent, Inc. valued at approximately $568,000 in the second quarter, marking a significant investment in the company.
• Confluent's quarterly revenue increased by 20.1% year-over-year, reporting $282.29 million and exceeding analyst expectations.
• Despite recent insider sales by executives, Confluent has a consensus rating of "Moderate Buy" from analysts, with an average price target of $27.25.

Lecap Asset Management Ltd. acquired a new position in shares of Confluent, Inc. (NASDAQ:CFLT - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 22,785 shares of the company's stock, valued at approximately $568,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CFLT. Vanguard Group Inc. grew its stake in shares of Confluent by 7.2% during the first quarter. Vanguard Group Inc. now owns 26,620,150 shares of the company's stock worth $623,976,000 after buying an additional 1,791,588 shares during the last quarter. Nuveen LLC bought a new position in shares of Confluent in the 1st quarter valued at $28,791,000. Principal Financial Group Inc. boosted its holdings in shares of Confluent by 47.3% during the 1st quarter. Principal Financial Group Inc. now owns 528,171 shares of the company's stock valued at $12,380,000 after acquiring an additional 169,576 shares in the last quarter. SWS Partners grew its position in Confluent by 29.9% during the 2nd quarter. SWS Partners now owns 139,464 shares of the company's stock worth $3,477,000 after acquiring an additional 32,134 shares during the last quarter. Finally, Strs Ohio bought a new stake in Confluent during the 1st quarter worth $618,000. Institutional investors own 78.09% of the company's stock.

Confluent Trading Up 4.1%

CFLT opened at $20.52 on Friday. Confluent, Inc. has a twelve month low of $15.64 and a twelve month high of $37.90. The company has a fifty day moving average of $19.36 and a 200-day moving average of $22.01. The stock has a market cap of $7.07 billion, a PE ratio of -21.83 and a beta of 0.96. The company has a quick ratio of 3.98, a current ratio of 3.98 and a debt-to-equity ratio of 1.03.

Confluent (NASDAQ:CFLT - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.09 EPS for the quarter, beating analysts' consensus estimates of $0.08 by $0.01. Confluent had a negative net margin of 29.27% and a negative return on equity of 27.34%. The business had revenue of $282.29 million for the quarter, compared to analysts' expectations of $278.32 million. During the same quarter in the prior year, the firm posted $0.06 earnings per share. The business's quarterly revenue was up 20.1% compared to the same quarter last year. Confluent has set its Q3 2025 guidance at 0.090-0.100 EPS. FY 2025 guidance at 0.360-0.360 EPS. On average, sell-side analysts predict that Confluent, Inc. will post -0.83 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Royal Bank Of Canada dropped their target price on Confluent from $28.00 to $25.00 and set an "outperform" rating for the company in a research report on Thursday, July 31st. Capital One Financial set a $21.00 price objective on Confluent in a research note on Thursday, July 31st. Raymond James Financial cut their target price on shares of Confluent from $30.00 to $25.00 and set an "outperform" rating on the stock in a research report on Thursday, July 31st. Cowen lowered shares of Confluent from a "buy" rating to a "hold" rating in a report on Thursday, July 31st. Finally, Stephens started coverage on shares of Confluent in a research note on Friday, July 18th. They set an "overweight" rating and a $31.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $27.25.

Insiders Place Their Bets

In other news, CFO Rohan Sivaram sold 5,000 shares of the firm's stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $20.00, for a total transaction of $100,000.00. Following the completion of the sale, the chief financial officer owned 631,596 shares of the company's stock, valued at $12,631,920. This trade represents a 0.79% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Edward Jay Kreps sold 232,500 shares of Confluent stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $18.66, for a total transaction of $4,338,450.00. Following the completion of the sale, the chief executive officer owned 377,074 shares of the company's stock, valued at $7,036,200.84. This represents a 38.14% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 741,584 shares of company stock valued at $13,597,695 in the last 90 days. Company insiders own 9.20% of the company's stock.

Confluent Profile

Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.